Markets:

Overview

News

Currencies

International

Treasuries

AgeX Therapeutics, Inc. Common Stock (NY:AGE)

N/A UNCHANGED

Last Price Updated: 8:00 PM EDT, Mar 26, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AgeX Therapeutics, Inc. Common Stock

< Previous 1 2 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 04, 2022

Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

61 Biggest Movers From Yesterday ↗

January 04, 2022

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

January 03, 2022

Gainers Immix Biopharma, Inc. (NASDAQ: IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-...

Via Benzinga

18 Stocks Moving in Monday's Pre-Market Session ↗

January 03, 2022

Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI...

Via Benzinga

40 Biggest Movers From Friday ↗

January 03, 2022

Gainers Nutriband Inc. (NASDAQ: NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Property Office has fully issued its...

Via Benzinga

Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology

December 31, 2021

VANCOUVER, British Columbia - Dec. 31, 2021 - PRLog -- 2020-07-30: Scientists now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead...

Via PRLog

Topics Artificial Intelligence Intellectual Property

AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders

December 14, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

November 30, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension ↗

November 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Puma Biotech Announces Receipt Of Patent Extension For Breast Cancer Drug By...

Via Benzinga

Topics Intellectual Property

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

November 23, 2021

From AgeX Therapeutics , Inc.

Via Business Wire

AgeX Therapeutics Reports Third Quarter 2021 Financial Results

November 12, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Second Quarter 2021 Financial Results

August 13, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

A Peek Into The Markets: US Stock Futures Down Following Friday's Rally ↗

July 26, 2021

Pre-open movers U.S. stock futures traded lower in early pre-market trade after all three major indexes settled at record highs in the previous session. China announced a set of...

Via Benzinga

5 Stocks To Watch For July 26, 2021 ↗

July 26, 2021

Some of the stocks that may grab investor focus today are: Wall Street expects Lockheed Martin Corporation (NYSE: LMT) to report quarterly earnings at $6.53 per share on revenue...

Via Benzinga

AgeX Therapeutics and LyGenesis Terminate Merger Negotiations

July 23, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

May 17, 2021

From AgeX Therapeutics

Via Business Wire

58 Biggest Movers From Yesterday ↗

April 27, 2021

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

April 26, 2021

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug...

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

April 26, 2021

Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 20.6% to $11.61 in pre-market trading. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd.,...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AgeX Therapeutics, Inc. Common Stock (NY:AGE)

All News about AgeX Therapeutics, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today